Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Change in Cash (2021 - 2025)

Historic Change in Cash for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $4.6 million.

  • Kezar Life Sciences' Change in Cash fell 3059.86% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 5123.21%. This contributed to the annual value of $6.3 million for FY2024, which is 22605.28% up from last year.
  • Per Kezar Life Sciences' latest filing, its Change in Cash stood at $4.6 million for Q3 2025, which was down 3059.86% from -$2.6 million recorded in Q2 2025.
  • In the past 5 years, Kezar Life Sciences' Change in Cash ranged from a high of $66.5 million in Q2 2022 and a low of -$40.9 million during Q3 2022
  • In the last 5 years, Kezar Life Sciences' Change in Cash had a median value of -$1.6 million in 2023 and averaged $931947.4.
  • Over the last 5 years, Kezar Life Sciences' Change in Cash had its largest YoY gain of 181361.54% in 2022, and its largest YoY loss of 152702.38% in 2022.
  • Kezar Life Sciences' Change in Cash (Quarter) stood at $5.8 million in 2021, then plummeted by 514.6% to -$24.0 million in 2022, then soared by 137.48% to $9.0 million in 2023, then decreased by 23.39% to $6.9 million in 2024, then tumbled by 33.71% to $4.6 million in 2025.
  • Its last three reported values are $4.6 million in Q3 2025, -$2.6 million for Q2 2025, and -$4.7 million during Q1 2025.